Latest / Honduras News Today | 2 Min News | The Daily News Now!
Breakthrough Pill Extends Pancreatic Cancer Survival | Honduras News
FDA just approved a groundbreaking new pill for advanced pancreatic cancer—daraxonrasib, now called Rasonque. Targeting the elusive RAS mutation found in 90% of cases, it nearly doubles survival time over chemo with far fewer side effects. Though pricey at $39,800 per month, this could be a game-changer for late-stage patients and open doors to similar treatments for other tough cancers. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.